Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 2225 of 3499 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/03
End: 11/30/09
Due: 11/30/10
Phase: N/A
Priority: Normal
Start: 09/14/05
End: 03/19/26
Due: 03/19/27
Phase: N/A
Priority: Normal
Start: 03/18/22
End: 10/01/26
Due: 10/01/27
Phase: N/A
Priority: Normal
Start: 07/16/19
End: 06/01/26
Due: 06/01/27
Phase: N/A
Priority: Normal
Start: 02/10/11
End: 01/29/14
Due: 01/29/15
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
Phase: N/A
Priority: Normal
Start: 04/01/01
End: 09/20/06
Due: 09/20/07
Phase: N/A
Priority: Normal
Start: 03/21/14
End: 12/01/22
Due: 12/01/23
Phase: N/A
Priority: Normal
Start: 02/28/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/18/01
End: 03/19/26
Due: 03/19/27
Phase: N/A
Priority: Normal
Start: 05/29/18
End: 05/10/22
Due: 05/10/23
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 07/11/22
End: 04/15/26
Due: 04/15/27
Phase: N/A
Priority: Normal
Start: 07/07/22
End: 09/01/25
Due: 09/01/26
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 01/12/11
End: 09/12/12
Due: 09/12/13
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 10/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 12/31/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 07/26/05
End: 05/20/22
Due: 05/20/23
Phase: N/A
Priority: Normal
Start: 10/31/04
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 01/13/11
End: 09/24/12
Due: 09/24/13